2018, FDA and Federal Policy - Health Care Compliance Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2018

FDA

Federal Policy

CMS Promotes Competition, Transparency, Health Equity and More in the CY2025 Medicare Advantage and Part D Proposed Rule

Healthcare Law Blog

NOVEMBER 13, 2023

1] Special Supplemental Benefits for the Chronically Ill (SSBCI) The Balanced Budget Act of 2018 introduced new authorities concerning supplemental benefits that may be offered to chronically ill enrollees in MA plans. This proposal would shift the burden from CMS to the MA organization to demonstrate compliance with this standard.

Medicare

Medicare Medicare Medicaid Medicaid

Federal Preemption of State Attempts To Ban FDA-Approved Abortion Drugs After Dobbs

Drug & Device Law

JUNE 28, 2022

June 24, 2022), we fully expect attempts by such states to ban FDA-approved prescription drugs that can be used to bring about abortions by chemical means. But when the FDA has approved a product, states no longer have the power to prohibit their sale or use for FDA-approved indications. Jackson Women’s Health Org. ,

FDA

FDA Public Health Federal Policy Doctors

CMS Promotes Competition, Transparency, Health Equity and More in the CY2025 Medicare Advantage and Part D Proposed Rule

Federal Preemption of State Attempts To Ban FDA-Approved Abortion Drugs After Dobbs

Stay Connected